alpinetin has been researched along with Liver Dysfunction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, S; Chen, S; Guo, W; Pan, J; Shi, X; Zhang, H; Zhang, J; Zhang, S | 1 |
1 other study(ies) available for alpinetin and Liver Dysfunction
| Article | Year |
|---|---|
Alpinetin protects against hepatic ischemia/reperfusion injury in mice by inhibiting the NF-κB/MAPK signaling pathways.
Topics: Animals; Flavanones; Liver; Liver Diseases; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; NF-kappa B; Protective Agents; Reperfusion Injury | 2021 |